This website is intended for international healthcare professionals with an interest in the treatment of Nocturia. By clicking the link below you are declaring and confirming that you are a healthcare professional. Please answer a few short questions about this resource centre.


What is a Resource Centre - and why focus on Nocturia

A Resource Centre is a freely accessible platform, designed for healthcare professionals, that aims to increase clinical knowledge in a specific medical specialty by disseminating important new research and clinical developments more broadly. Resource Centres are all independently editorially controlled, provided in collaboration with established medical journals, hosted and managed by Elsevier, and funded by educational grants from societies and other organizations, such as medical or pharmaceutical companies.

Nocturia is an important area medically and has a significant impact on quality of life. The Nocturia Resource Centre aims to increase awareness and knowledge about all aspects of Nocturia. Urologists are the primary specialist who will see patients with this problem and it is expected that they will play a major role in the further diagnosis and organization of treatment.

Published this month

  • Lower Urinary Tract Symptoms in Women with Diabetes Mellitus: A Current Review

    From: Rebecca James & Adonis Hijaz

    Current Urology Reports, Volume 15, Issue 10, 1 October 2014

    Editor’s comments:
    Several studies before have indicated the presence of a strong association between lower urinary tract symptoms (LUTS) and Diabetes Mellitus in women  affected by the disease. As an example, in examining the prevalence of stress, urge, and mixed urinary incontinence and associated risk factors in postmenopausal women, a significantly higher prevalence has been reported in diabetic women compared to non-diabetic ones. The authors of this review conducted a literature review of the most current publications studying LUTS in women affected by Diabetes Mellitus, which included...

  • Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)

    From: R. Berges, K. Höfner, M. Gedamke and M. Oelke.

    World Journal of Urology, Volume 32, Issue 5, pages 1163-1170, October 2014

    Editor’s comments:
    This multicenter study was conducted in 69 centers across Germany and included 137 men affected by LUTS/BPH with nocturia due to nocturnal polyuria (NP), and who were treated with desmopressin. 

    Included patients exhibiting ≥2 nocturia episodes/night due to NP, and who started desmopressin treatment in a 3-month period between January 2009 and March 2010. Desmopressin 0.1 mg before going to bed was the first dose proposed to patients; which could be increased or decreased by request of the patient after one week, to....


About the Editors

Congress Planner



Ferring Pharmaceuticals LogoMade possible by an
educational grant
from Ferring


Register to be notified when new content is published. Only your name, country and email address needed.


New Associate Editor, Professor Karl-Erik Andersson

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.
The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views.

Book on Nocturia!

Nocturia: Causes, Consequences and Clinical Approaches Is the first volume exclusively on the topic of nocturia and is designed to be a comprehensive treatise on the subject.


Search form